These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 24462426)

  • 21. Acquired predisposition to mycobacterial disease due to autoantibodies to IFN-gamma.
    Kampmann B; Hemingway C; Stephens A; Davidson R; Goodsall A; Anderson S; Nicol M; Schölvinck E; Relman D; Waddell S; Langford P; Sheehan B; Semple L; Wilkinson KA; Wilkinson RJ; Ress S; Hibberd M; Levin M
    J Clin Invest; 2005 Sep; 115(9):2480-8. PubMed ID: 16127458
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Severe Paradoxical Reaction During Treatment of Disseminated Tuberculosis in a Patient With Neutralizing Anti-IFNγ Autoantibodies.
    Xie YL; Rosen LB; Sereti I; Barber DL; Chen RY; Hsu DC; Qasba SS; Zerbe CS; Holland SM; Browne SK
    Clin Infect Dis; 2016 Mar; 62(6):770-773. PubMed ID: 26646678
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mycobacterium avium complex empyema in a patient with interferon gamma autoantibodies.
    DeLeon TT; Chung HH; Opal SM; Dworkin JD
    Hawaii J Med Public Health; 2014 Sep; 73(9 Suppl 1):15-7. PubMed ID: 25285250
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adult-onset immunodeficiency in Thailand and Taiwan.
    Browne SK; Burbelo PD; Chetchotisakd P; Suputtamongkol Y; Kiertiburanakul S; Shaw PA; Kirk JL; Jutivorakool K; Zaman R; Ding L; Hsu AP; Patel SY; Olivier KN; Lulitanond V; Mootsikapun P; Anunnatsiri S; Angkasekwinai N; Sathapatayavongs B; Hsueh PR; Shieh CC; Brown MR; Thongnoppakhun W; Claypool R; Sampaio EP; Thepthai C; Waywa D; Dacombe C; Reizes Y; Zelazny AM; Saleeb P; Rosen LB; Mo A; Iadarola M; Holland SM
    N Engl J Med; 2012 Aug; 367(8):725-34. PubMed ID: 22913682
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incorrect diagnoses in patients with neutralizing anti-interferon-gamma-autoantibodies.
    Wu UI; Wang JT; Sheng WH; Sun HY; Cheng A; Hsu LY; Chang SC; Chen YC
    Clin Microbiol Infect; 2020 Dec; 26(12):1684.e1-1684.e6. PubMed ID: 32120037
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Juvenile-Onset Immunodeficiency Secondary to Anti-Interferon-Gamma Autoantibodies.
    Liew WK; Thoon KC; Chong CY; Tan NWH; Cheng DT; Chan BSW; Ng MSY; Das L; Arkachaisri T; Huang CH; Kuan JL; Chai LYA; Koh MJA
    J Clin Immunol; 2019 Jul; 39(5):512-518. PubMed ID: 31177358
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional neutralization of anti-IFN-γ autoantibody in patients with nontuberculous mycobacteria infection.
    Krisnawati DI; Liu YC; Lee YJ; Wang YT; Chen CL; Tseng PC; Lin CF
    Sci Rep; 2019 Apr; 9(1):5682. PubMed ID: 30952894
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Repurposing QuantiFERON for Detection of Neutralizing Interferon-γ Autoantibodies in Patients With Nontuberculous Mycobacterial Infections.
    Suárez I; Lehmann C; Gruell H; Graeb J; Kochanek M; Fätkenheuer G; Plum G; van Wengen A; van de Vosse E; Hartmann P; Hanitsch LG; Rybniker J
    Clin Infect Dis; 2017 Aug; 65(3):518-521. PubMed ID: 28430999
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of a major epitope by anti-interferon-γ autoantibodies in patients with mycobacterial disease.
    Lin CH; Chi CY; Shih HP; Ding JY; Lo CC; Wang SY; Kuo CY; Yeh CF; Tu KH; Liu SH; Chen HK; Ho CH; Ho MW; Lee CH; Lai HC; Ku CL
    Nat Med; 2016 Sep; 22(9):994-1001. PubMed ID: 27525523
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Disseminated cutaneous Mycobacterium kansasii infection presenting with Rosai-Dorfman disease-like histological features in a patient carrying anti-interferon-γ autoantibodies.
    King YA; Hu CH; Lee YJ; Lin CF; Liu D; Wang KH
    J Dermatol; 2017 Dec; 44(12):1396-1400. PubMed ID: 28836691
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patient ethnicity and causative species determine the manifestations of anti-interferon-gamma autoantibody-associated nontuberculous mycobacterial disease: a review.
    Hase I; Morimoto K; Sakagami T; Ishii Y; van Ingen J
    Diagn Microbiol Infect Dis; 2017 Aug; 88(4):308-315. PubMed ID: 28633901
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tuberculosis antigen-induced expression of IFN-α in tuberculosis patients inhibits production of IL-1β.
    Ma J; Yang B; Yu S; Zhang Y; Zhang X; Lao S; Chen X; Li B; Wu C
    FASEB J; 2014 Jul; 28(7):3238-48. PubMed ID: 24675363
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Evolution of IGRA researches].
    Ariga H; Harada N
    Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neutralizing Activity of Anti-interferon-γ Autoantibodies in Adult-Onset Immunodeficiency Is Associated With Their Binding Domains.
    Yasamut U; Thongkum W; Moonmuang S; Sakkhachornphop S; Chaiwarith R; Praparattanapan J; Wipasa J; Chawansuntati K; Supparatpinyo K; Lai E; Tayapiwatana C
    Front Immunol; 2019; 10():1905. PubMed ID: 31474987
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disseminated Mycobacterium haemophilum skeletal disease in a patient with interferon-gamma deficiency.
    Otome O; O'Reilly M; Lim L
    Intern Med J; 2015 Oct; 45(10):1073-6. PubMed ID: 26429217
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Partial interferon-gamma receptor deficiency and non-tuberculous mycobacterial lung disease.
    Hwang JH; Koh WJ; Kim EJ; Kang EH; Suh GY; Chung MP; Kim H; Kwon OJ
    Tuberculosis (Edinb); 2006 Sep; 86(5):382-5. PubMed ID: 16682253
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Subcutaneous injection of interferon gamma therapy could be useful for anti-IFN-γ autoantibody associated disseminated nontuberculous mycobacterial infection.
    Harada M; Furuhashi K; Karayama M; Suzuki Y; Hozumi H; Enomoto N; Fujisawa T; Nakamura Y; Inui N; Suda T
    J Infect Chemother; 2021 Feb; 27(2):373-378. PubMed ID: 33071037
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-CD20 (rituximab) therapy for anti-IFN-γ autoantibody-associated nontuberculous mycobacterial infection.
    Browne SK; Zaman R; Sampaio EP; Jutivorakool K; Rosen LB; Ding L; Pancholi MJ; Yang LM; Priel DL; Uzel G; Freeman AF; Hayes CE; Baxter R; Cohen SH; Holland SM
    Blood; 2012 Apr; 119(17):3933-9. PubMed ID: 22403254
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Non-tuberculous mycobacterial infection and reactive dermatosis associated with adult-onset immunodeficiency due to anti-interferon-gamma autoantibodies: A case report.
    Liang XN; Bin YF; Lai GT; Li YH; Zhang JQ; Zhong XN; Bai J; Li MH; Deng JM; He ZY
    Medicine (Baltimore); 2020 Sep; 99(36):e21738. PubMed ID: 32899003
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polymorphisms of interferon-gamma and interferon-gamma receptor 1 genes and non-tuberculous mycobacterial lung diseases.
    Hwang JH; Kim EJ; Koh WJ; Kim SY; Lee SH; Suh GY; Kwon OJ; Ki CS; Ji Y; Kang M; Kim DH
    Tuberculosis (Edinb); 2007 Mar; 87(2):166-71. PubMed ID: 17023216
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.